New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 8, 2014
08:58 EDTPPHM, PNT, SNTAThree pharma companies have good partnering prospects, says Roth Capital
Roth Capital believes that Peregrine (PPHM), Palatin (PTN), and Synta (SNTA) have good odds of signing partnership deals in the "relative near term." The firm keeps Buy ratings on all three stocks.
News For PPHM;PNT;SNTA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 30, 2014
09:47 EDTPPHMPeregrine says data trends continue to support bavituximab's potential in NSCLC
Subscribe for More Information
October 29, 2014
07:09 EDTSNTASynta Pharmaceuticals announces initiation of I-SPY 2 trial of Ganetespib
Subscribe for More Information
October 27, 2014
18:05 EDTPPHMNYC boy with Ebola-like symptoms tests negative for disease, WSJ says
Subscribe for More Information
11:24 EDTPPHMNovavax rises after announcing Ebola vaccine development program
Subscribe for More Information
07:27 EDTPPHMYoung NYC boy tested for Ebola, NY Post reports
Subscribe for More Information
October 26, 2014
14:40 EDTPPHMFDA issues Emergency Use Authorization for Ebola diagnostic tests
Subscribe for More Information
October 24, 2014
10:55 EDTPPHMDallas nurse now Ebola virus free, to be released, NBC reports
NBC and other media outlets cites NIH on Nina Pham's release. Drug companies that are working on experimental Ebola vaccines or treatments include Peregrine (PPHM), Tekmira (TKMR), Sarepta (SRPT), BioCryst (BCRX), Chimerix (CMRX) and NewLink Genetics (NLNK). Some companies that offer protective clothing and waste disposal include Lakeland Industries (LAKE), Alpha Pro Tech (APT) and Sharps Compliance (SMED). Reference Link
October 23, 2014
15:25 EDTPPHMNew York confirms health care worker being tested for Ebola
Subscribe for More Information
06:22 EDTPPHMEU to boost Ebola research with EUR 24.4M
The European Commission has today announced EUR 24.4M from the EU budget for urgently needed Ebola research. The funding will go to five projects, ranging from a large-scale clinical trial of a potential vaccine, to testing existing and novel compounds to treat Ebola. The money from Horizon 2020, the EU research and innovation program, will be provided via a fast-track procedure in order to start work as soon as possible. The Commission is also working with industry on the further development of vaccines, drugs and diagnostics for Ebola and other haemorrhagic diseases within the Innovative Medicines Initiative. The funding will be provided following proposals from teams across the EU and in numerous 3rd countries, which were evaluated by an independent group of experts. The Commission has also asked the European and Developing Countries Clinical Trials Partnership to include emerging epidemics of concern to Africa, including Ebola, in its work plan. This will allow to fund clinical trials on drugs, vaccines and diagnostics in upcoming calls. Drug companies that are working on experimental Ebola vaccines or treatments include Peregrine (PPHM), Tekmira (TKMR), Sarepta (SRPT), BioCryst (BCRX), Chimerix (CMRX) and NewLink Genetics (NLNK). Some companies that offer protective clothing and waste disposal include Lakeland Industries (LAKE), Alpha Pro Tech (APT) and Sharps Compliance (SMED).
October 22, 2014
06:41 EDTPPHMWHO fast-tracking testing of two Ebola vaccines, Guardian reports
Subscribe for More Information
October 17, 2014
14:50 EDTPPHMBARDA asks labs to ramp up Zmapp production, Reuters says
Subscribe for More Information
09:46 EDTPPHMSarepta soars after publication of Ebola drug candidate data
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use